Functional neurological disorders Flashcards

(29 cards)

1
Q

objectives of personalised mx for fnd

A

understand all dx present and their interactions
understand the person and their system
use the information to provide a tailored diagnostic explanation to the person and their family
evidence based tailored mx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the Objective of Non-Personalised Management?

A

a transaction of exchanging symptoms for a medical phrase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

clinicians should make sure to proactively ask about…

A

pain
fatigue
cognitive sx
bladder
sleep
dissociation
normality/ variability
emotional sx (last)
anxiety and panic
risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

multidisciplinary education sessions for fnd (cope et al 2021)

A

single education session
self-report of understanding, acceptance, treatability belief and hopefulness of dx and recovering at the beginning and end of session
significant increase in all variables

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Guided self-help for functional (psychogenic) symptoms (Sharpe et al 2011)

A

CBT guided self help + usual care
GSH comprised a self-help manual and 4 half-hour guidance sessions
self rated
greater improvement for gsh group

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

physio4fmd

A

9 sessions over 3 weeks plus 3 month follow up
- ax
- education
- movement retraining
- acknowledge/ address pain and fatigue
- develop a self mx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what are the movement retraining strategies in physio4fmd

A

redirect attention to elicit automatic movement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

physio4fmd outcomes at 12 months

A

physical functioning SF36

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

physio4fmd secondary outcomes at 6 and 12 months

A

clinical global impression scale of improvement
SF36
functional mobility scale
HADS
fatigue scale
confidence in dx
revised illness perception questionnaire
hospital admission and appointments

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

physio4fmd tx

A

specialist phsyio vs tx
high satisfaction in both groups 97% vs 65%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Multicenter pilot treatment trial for psychogenic nonepileptic seizures (lafrance et al 2014)

A

Medication (flexible-dose sertraline hydrochloride) only, cognitive behavioral therapy informed psychotherapy (CBT-ip) only, CBT-ip with medication (sertraline), or treatment as usual.
Seizure frequency was the primary outcome
The psychotherapy (CBT-ip) arm showed a 51.4% seizure reduction (P = .01)
significant improvement from baseline in secondary measures
The combined arm (CBT-ip with sertraline) showed 59.3% seizure reduction (P = .008)
The sertraline-only arm did not show a reduction in seizures (P = .08).
The treatment as usual group showed no significant seizure reduction or improvement in secondary outcome measures (P = .19).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

CODES trial (goldstein 2020)

A

We aimed to compare the effectiveness of cognitive behavioural therapy (CBT) plus standardised medical care with standardised medical care alone for the reduction of dissociative seizure frequency.
The primary outcome was monthly dissociative seizure frequency
At 12 months, no significant difference in monthly dissociative seizure frequency was identified between the groups
However, improvements were observed in a number of clinically relevant secondary outcomes following CBT plus standardised medical care vs standard care only

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what was standard care in the CODES trial

A

information about the seizures dx by an epileptologist or neurologist
neurology trial specific information booklet about dissociative seizures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

psychotherapy for fnd (gutkin et al. 2021, systematic review)

A

single symptom-based subtype
effect sizes with medium sized benefit for physical symptoms, mental health, well-being, function and resource use for both CBT and PDT
lack of high-quality controlled trials of PDT is a significant limitation
lack of long-term follow-up data in the majority of identified CBT trials

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

MODIFI - EMDR for FND (cope 2023)

A

EMDR (plus standard neuropsychiatric care; NPC) and standard NPC
comparisons at baseline (T0), 3 months (T1), 6 months (T2) and 9 months (T3)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what are the eight phases of emdr

A

I-II: pt hx, ax of suitability and preparation
III: ax of target image, identify negative and positive cognitions, rate subjective distress
IV: desensitisation phase with eye movement
V: installation of positive cognition
VI: target remaining distress
VII: end session
VIII: ax and determine need for further sessions

17
Q

what does emdr stand for

A

eye movement desensitisation and reprocessing therapy

18
Q

neuromodulation for fnd

A

repetitive transcranial magnetic stimulation (rTMS)
intermittent theta-burst stimulation (iTBS)
transcranial direct current stimulation (tDCS)
transcutaneous electrical nerve stimulation (TENS)
potential targets: motor cortex, temporoparietal junction
dorsolateral prefrontal cortex

19
Q

rTMS for functional neurological paresis

A

active 15 Hz rTMS over the contralateral motor cortex (hand area) vs rTMS + placebo
Primary outcome measure was change in muscle strength as measured by dynamometry
rTMS + placebo - active rTMS induced a significantly larger median increase in objectively measured muscle strength vs placebo TMS

20
Q

TMS on functional movement disorders cortical modulation vs behavioural

A

cortex contralateral to the symptoms or over the spinal roots homolateral
RMS + TMS vs TMS + RMS
assessed the severity of movement disorders before and after each stimulation session
The magnetic stimulation sessions led to a significant improvement in 66%
no difference between TMS and RMS

21
Q

right TPJ TMS as a therapeutic target for PNES

A

video-EEG documented PNES without comorbid epileptic seizures were recruited
decrease in weekly seizure rates post vs. pre-treatment, which was sustained at 3-month follow-up

22
Q

therapeutic sedation for functional neurological sx

A

propofol in severe fnd can be a useful adjunct for patients

24
Q

psychedelics for FND

A

increased default mode network connectivity is reduced following a dose of psilocybin

25
formulation informed tx
Build the formulation of potential factors affecting treatment response collaboratively with the person with FMD Establish formulation-driven, shared, value-based, and goal-directed treatment plans Measure outcomes Agree a time frame for treatment and re-evaluation…which includes stopping.
26
what are the factors of difficult to treat FMD and suboptimal treatment response
reassess formulation person centred factors person related factors illness related factors treatment factors formulation informed tx
27
personality, trauma and neurodiversity
personality - include obsessive-compulsive and personality disorder traits trauma - ptsd and ace increase severity and decrease physical health neurodiversity - high prevalence in FND
28
prodromal FND
e.g. in parkinsons disease
29
implementation problems
complexity is not the same as technically complicated can't objectively measure complex interventions